Discovery history and clinical development of mirabegron for the treatment of overactive bladder and urinary incontinence

Author： Sacco Emilio   Bientinesi Riccardo   Tienforti Daniele   Racioppi Marco   Gulino Gaetano   D'Agostino Daniele   Vittori Matteo   Bassi Pierfrancesco  

Publisher： Informa Healthcare

ISSN： 1746-0441

Source： Expert Opinion on Drug Discovery, Vol.9, Iss.4, 2014-04, pp. : 433-448

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Mirabegron in the treatment of overactive bladder

By Leone Roberti Maggiore Umberto   Cardozo Linda   Ferrero Simone   Sileo Filomena   Cola Alice   Torella Marco   Colacurci Nicola   Candiani Massimo   Salvatore Stefano  

Expert Opinion on Pharmacotherapy, Vol. 15, Iss. 6, 2014-04 ,pp. : 873-887

Informa Healthcare

Access to resources Recommend Favorite

Oxybutynin for treatment of urge urinary incontinence and overactive bladder: an updated review

By Abramov Yoram   Sand Peter K  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 11, 2004-11 ,pp. : 2351-2359

Informa Healthcare

Access to resources Recommend Favorite

Pharmacological agents for the treatment of urinary incontinence due to overactive bladder

By Wein A.J.  

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 1, 2001-01 ,pp. : 65-83

Informa Healthcare

Access to resources Recommend Favorite

Clinical Burden and Nonpharmacologic Management of Nursing Facility Residents with Overactive Bladder and/or Urinary Incontinence

By ZarowitzBarbara J.Omnicare   Inc.   Cincinnati   Ohio   USA   AllenCarrie   O'SheaTerrence   TangalosEric   BernerTodd   OuslanderJoseph G.  

The Consultant Pharmacist, Vol. 30, Iss. 9, 2015-09 ,pp. : 533-542

American Society of Consultant Pharmacists

Access to resources Recommend Favorite

The pharmacokinetic evaluation of mirabegron as an overactive bladder therapy option

By Kashyap Mahendra   Tyagi Pradeep  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 5, 2013-05 ,pp. : 617-627

Informa Healthcare

Access to resources Recommend Favorite